CBH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Coloplast A/S

Watchlist Manager

Watchlist

Price: 5.65 EUR Market Closed

Market Cap: €12.7B

C	Coloplast A/S F:CBH	DK
H	Heidelberg Pharma AG XHAM:HPHA	DE

Profitability Summary

Coloplast A/S's profitability score is 59/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

67%

Strong 3Y Average Gross Margin

67%

Gross Margin is Increasing

67% > 67%

Healthy Operating Margin

27%

Sustainable 3Y Average Operating Margin

27%

Declining Operating Margin

29% > 27%

Low Net Margin

Sustainable 3Y Average Net Margin

16%

Declining Net Margin

20% > 8%

Exceptional Free Cash Flow Margin

21%

Strong 3Y Average Free Cash Flow Margin

13%

Free Cash Flow Margin is Increasing

13% > 21%

Positive ROE

13%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

12%

Declining ROIC

16% > 10%

View All

Hide

Collapse

59 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.